Bio-Techne Corporation, together with its subsidiaries, develops, manufactures, and sells life science reagents, instruments, and services for the research and clinical diagnostic markets worldwide. The company operates through two segments, Protein Sciences, and Diagnostics and Genomics. The Protein Sciences segment develops and manufactures biological reagents used in various aspects of life science research, diagnostics, and cell and gene therapy, such as cytokines and growth factors, antibodies, small molecules, tissue culture sera, and cell selection technologies. This segment also offers proteomic analytical tools for automated western blot and multiplexed ELISA workflow consists of manual and automated protein analysis instruments and immunoassays for use in quantifying proteins in various biological fluids. The Diagnostics and Genomics segment develops and manufactures diagnostic products, including controls, calibrators, and diagnostic assays for regulated diagnostics market, exosome-based molecular diagnostic assays, advanced tissue-based in-situ hybridization assays for spatial genomic and tissue biopsy analysis, and genetic and oncology kits for research and clinical applications; and sells products for genetic carrier screening, oncology diagnostics, molecular controls, and research, as well as instruments and process control products for hematology, blood chemistry and gases, and coagulation controls and reagents used in various diagnostic applications. It offers its products under R&D Systems, Tocris Biosciences, Novus Biologicals, ProteinSimple, Advanced Cell Diagnostics, Exosome Diagnostics, and Asuragen brands. The company was formerly known as Techne Corporation and changed its name to Bio-Techne Corporation in November 2014. Bio-Techne Corporation was founded in 1976 and is headquartered in Minneapolis, Minnesota.


Bio-Techne Corporation develops, manufactures and sells life science reagents, instruments and services for the research, diagnostic, and bioprocessing markets. The company's brands include R&D Systems, ProteinSimple, and Novus Biologicals.

The company was founded in 1976 by Dr. Roger C. Lucas as Research and Diagnostic Systems, Inc. In 1985, it merged into Techne Corporation and became a public company.

In March 2013, Charles (Chuck) Kummeth was named chief executive officer of the company.

EPIC tools for EPIC science

To continually deliver novel and innovative life science tools that drive progress in research and drug discovery.

Key Team

Mr. Kim Kelderman (Pres of Diagnostics & Genomics)

Mr. William A. Geist (Pres of Protein Sciences Segment)

David Clair (Sr. Director of Investor Relations & Corp. Devel.)

Mr. Robert M. Gavin (VP of Corp. Devel.)

Mr. Gerry Andros (VP of Sales and Marketing)

Ms. Brenda S. Everson (Sr. VP & Chief HR Officer)

Mr. Luca Cicchetti (Managing Director)

Recognition and Awards
In 2019 Bio-Techne was recognized as the Developing Innovator award by the Minnesota High Tech Association.

Leadership team

Mr. Charles R. Kummeth (CEO, Pres & Director)

Mr. James T. Hippel (Exec. VP of Fin. & CFO)

Ms. Brenda S. Furlow J.D. (Exec. VP, Gen. Counsel, Sec. & Chief Compliance Officer)

Products/ Services
Biotechnology, Manufacturing
Number of Employees
1,000 - 20,000
Minneapolis, Minnesota, United States
Company Registration
SEC CIK number: 0000842023
Net Income
100M - 500M
Above - 1B
Social Media
Fri Mar 01 2024

businessabc offers a global business, SMEs wiki directory blockchain, NFTs, AI powered marketplace for businesses worldwide.

Follow Us
Produced by
In collaboration with

Copyright 2023 © businessabc powered by ztudium